Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 104

1.

Chronic treatment with mood-stabilizers attenuates abnormal hyperlocomotion of GluA1-subunit deficient mice.

Maksimovic M, Vekovischeva OY, Aitta-aho T, Korpi ER.

PLoS One. 2014 Jun 16;9(6):e100188. doi: 10.1371/journal.pone.0100188. eCollection 2014.

2.

Reversal of novelty-induced hippocampal c-Fos expression in GluA1 subunit-deficient mice by chronic treatment targeting glutamatergic transmission.

Maksimovic M, Aitta-aho T, Korpi ER.

Eur J Pharmacol. 2014 Dec 15;745:36-45. doi: 10.1016/j.ejphar.2014.10.005. Epub 2014 Oct 18.

PMID:
25446922
3.

Reversal of novelty-induced hyperlocomotion and hippocampal c-Fos expression in GluA1 knockout male mice by the mGluR2/3 agonist LY354740.

Procaccini C, Maksimovic M, Aitta-Aho T, Korpi ER, Linden AM.

Neuroscience. 2013 Oct 10;250:189-200. doi: 10.1016/j.neuroscience.2013.07.010. Epub 2013 Jul 15.

PMID:
23867766
4.

Lithium attenuates behavioral and biochemical effects of neuropeptide S in mice.

Castro AA, Casagrande TS, Moretti M, Constantino L, Petronilho F, Guerra GC, Calo' G, Guerrini R, Dal-Pizzol F, Quevedo J, Gavioli EC.

Peptides. 2009 Oct;30(10):1914-20. doi: 10.1016/j.peptides.2009.07.004. Epub 2009 Jul 16.

PMID:
19616051
5.

Excessive novelty-induced c-Fos expression and altered neurogenesis in the hippocampus of GluA1 knockout mice.

Procaccini C, Aitta-aho T, Jaako-Movits K, Zharkovsky A, Panhelainen A, Sprengel R, Linden AM, Korpi ER.

Eur J Neurosci. 2011 Jan;33(1):161-74. doi: 10.1111/j.1460-9568.2010.07485.x. Epub 2010 Nov 14.

PMID:
21073553
6.

Lithium treatment attenuates muscarinic M(1) receptor dysfunction.

Creson TK, Austin DR, Shaltiel G, McCammon J, Wess J, Manji HK, Chen G.

Bipolar Disord. 2011 May;13(3):238-49. doi: 10.1111/j.1399-5618.2011.00915.x.

PMID:
21676127
7.

The extracellular signal-regulated kinase pathway contributes to the control of behavioral excitement.

Engel SR, Creson TK, Hao Y, Shen Y, Maeng S, Nekrasova T, Landreth GE, Manji HK, Chen G.

Mol Psychiatry. 2009 Apr;14(4):448-61. doi: 10.1038/sj.mp.4002135. Epub 2008 Jan 29.

8.

[Antipsychotics in bipolar disorders].

Vacheron-Trystram MN, Braitman A, Cheref S, Auffray L.

Encephale. 2004 Sep-Oct;30(5):417-24. Review. French.

PMID:
15627046
9.

Effects of lithium and valproate on amphetamine-induced oxidative stress generation in an animal model of mania.

Frey BN, Valvassori SS, RĂ©us GZ, Martins MR, Petronilho FC, Bardini K, Dal-Pizzol F, Kapczinski F, Quevedo J.

J Psychiatry Neurosci. 2006 Sep;31(5):326-32.

10.

Effects of mood stabilizers on marble-burying behavior in mice: involvement of GABAergic system.

Egashira N, Abe M, Shirakawa A, Niki T, Mishima K, Iwasaki K, Oishi R, Fujiwara M.

Psychopharmacology (Berl). 2013 Mar;226(2):295-305. doi: 10.1007/s00213-012-2904-9. Epub 2012 Oct 21.

PMID:
23086022
11.

The mGlu2 but not the mGlu3 receptor mediates the actions of the mGluR2/3 agonist, LY379268, in mouse models predictive of antipsychotic activity.

Woolley ML, Pemberton DJ, Bate S, Corti C, Jones DN.

Psychopharmacology (Berl). 2008 Feb;196(3):431-40. Epub 2007 Dec 5.

PMID:
18057917
12.

Inhibition of specific adenylyl cyclase isoforms by lithium and carbamazepine, but not valproate, may be related to their antidepressant effect.

Mann L, Heldman E, Bersudsky Y, Vatner SF, Ishikawa Y, Almog O, Belmaker RH, Agam G.

Bipolar Disord. 2009 Dec;11(8):885-96. doi: 10.1111/j.1399-5618.2009.00762.x.

PMID:
19922557
13.
14.

Antipsychotic drugs prevent the motor hyperactivity induced by psychotomimetic MK-801 in zebrafish (Danio rerio).

Seibt KJ, Oliveira Rda L, Zimmermann FF, Capiotti KM, Bogo MR, Ghisleni G, Bonan CD.

Behav Brain Res. 2010 Dec 25;214(2):417-22. doi: 10.1016/j.bbr.2010.06.014. Epub 2010 Jun 20.

PMID:
20600350
15.

Evaluation of the effects of lamotrigine, valproate and carbamazepine in a rodent model of mania.

Arban R, Maraia G, Brackenborough K, Winyard L, Wilson A, Gerrard P, Large C.

Behav Brain Res. 2005 Mar 7;158(1):123-32.

PMID:
15680200
16.

Effects of neuronal Kv7 potassium channel activators on hyperactivity in a rodent model of mania.

Redrobe JP, Nielsen AN.

Behav Brain Res. 2009 Mar 17;198(2):481-5. doi: 10.1016/j.bbr.2008.12.027. Epub 2008 Dec 31.

PMID:
19162078
17.
18.

Lithium ameliorates phenotypic deficits in a mouse model of fragile X syndrome.

Liu ZH, Chuang DM, Smith CB.

Int J Neuropsychopharmacol. 2011 Jun;14(5):618-30. doi: 10.1017/S1461145710000520. Epub 2010 May 25.

19.

GluN2C/GluN2D subunit-selective NMDA receptor potentiator CIQ reverses MK-801-induced impairment in prepulse inhibition and working memory in Y-maze test in mice.

Suryavanshi PS, Ugale RR, Yilmazer-Hanke D, Stairs DJ, Dravid SM.

Br J Pharmacol. 2014 Feb;171(3):799-809. doi: 10.1111/bph.12518.

20.

Employing pharmacologic treatment of bipolar disorder to greatest effect.

Schatzberg AF.

J Clin Psychiatry. 2004;65 Suppl 15:15-20. Review.

PMID:
15554791
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk